SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem informs about disclosure

19 Aug 2024 Evaluate
Pursuant to Regulation 30 the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that the Company has received Certificate of suitability No. CEP 2022-160 - Rev 00, from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its product FLUNIXIN MEGLUMINE. This certificate facilitates registration and use of FLUNIXIN MEGLUMINE manufactured by the company by the European customers for their finished product.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

2282.60 27.55 (1.22%)
17-Apr-2026 12:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.00
Dr. Reddys Lab 1227.00
Cipla 1238.90
Zydus Lifesciences 943.65
Lupin 2310.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×